Harwood Rowan H, Sahota Opinder, Gaynor Kay, Masud Tahir, Hosking David J
Health Care of the Elderly, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Age Ageing. 2004 Jan;33(1):45-51. doi: 10.1093/ageing/afh002.
survivors of hip fracture are at 5- to 10-fold risk of a second hip fracture. There is little consensus about secondary prevention. Many are given calcium and vitamin D, but the evidence supporting this is circumstantial.
to compare the effects of different calcium and vitamin D supplementation regimens on bone biochemical markers, bone mineral density and rate of falls in elderly women post-hip fracture.
randomised controlled trial.
orthogeriatric rehabilitation ward.
150 previously independent elderly women, recruited following surgery for hip fracture, were assigned to receive a single injection of 300,000 units of vitamin D(2), injected vitamin D(2) plus 1 g/day oral calcium, 800 units/day oral vitamin D(3) plus 1 g/day calcium, or no treatment. Follow-up was one year, with measurement of 25-hydroxyvitamin D, parathyroid hormone, bone mineral density, and falls.
mean 25-hydroxyvitamin D increased and mean parathyroid hormone was suppressed in all the actively treated groups, more so in the group receiving combined oral vitamin D and calcium. Twenty per cent of participants injected with vitamin D were deficient in 25-hydroxyvitamin D a year later. Bone mineral density showed small but statistically significant differences of up to 4.6% between actively treated groups and placebo. Relative risk of falling in the groups supplemented with vitamin D was 0.48 (95% CI 0.26-0.90) compared with controls.
Vitamin D supplementation, either orally or with injected vitamin D, suppresses parathyroid hormone, increases bone mineral density and reduces falls. Effects may be more marked with calcium co-supplementation. The 300,000 units of injected vitamin D may not last a whole year.
髋部骨折幸存者再次发生髋部骨折的风险是常人的5至10倍。对于二级预防,人们几乎没有达成共识。许多人会补充钙和维生素D,但支持此举的证据并不确凿。
比较不同钙和维生素D补充方案对髋部骨折后老年女性骨生化指标、骨密度和跌倒发生率的影响。
随机对照试验。
老年骨科康复病房。
150名髋部骨折术后招募的既往生活自理的老年女性被分配接受单次注射30万单位维生素D₂、注射维生素D₂加每日口服1克钙、每日口服800单位维生素D₃加每日1克钙或不接受治疗。随访一年,测量25-羟维生素D、甲状旁腺激素、骨密度和跌倒情况。
所有积极治疗组的平均25-羟维生素D均升高,平均甲状旁腺激素均受到抑制,联合口服维生素D和钙的组更为明显。注射维生素D的参与者中有20%在一年后25-羟维生素D缺乏。积极治疗组与安慰剂组之间的骨密度显示出微小但具有统计学意义的差异,高达4.6%。与对照组相比,补充维生素D组的跌倒相对风险为0.48(95%可信区间0.26 - 0.90)。
口服或注射维生素D补充剂可抑制甲状旁腺激素,增加骨密度并减少跌倒。联合补充钙时效果可能更显著。注射30万单位维生素D可能无法维持一整年。